Achaogen Appoints Halley Gilbert to Its Board of Directors
Jan 05, 2017 13:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Perceptron Schedules Second-Quarter 2017 Conference Call/ Webcast for February 7, 2017
Jan 05, 2017 13:30 pm UTC| Business
PLYMOUTH, Mich., Jan. 05, 2017 -- Perceptron, Inc. (NASDAQ:PRCP) will hold its conference call/webcast to discuss financial results for the second quarter and six months ended December 31, 2016, on Tuesday, February 7,...
Manhattan Associates Announces Date for Reporting Fourth Quarter 2016 Financial Results
Jan 05, 2017 13:30 pm UTC| Business
ATLANTA, Jan. 05, 2017 -- Supply Chain Commerce Solutions leaderManhattan Associates, Inc. (NASDAQ:MANH) today announced it will release its fourth quarter 2016 financial results on Tuesday, January 31, 2017, after the...
Proofpoint to Report Fourth Quarter and Full Year 2016 Financial Results
Jan 05, 2017 13:30 pm UTC| Business
SUNNYVALE, Calif., Jan. 05, 2017 -- Proofpoint, Inc. (NASDAQ:PFPT), a leading next-generation security and compliance company, today announced it will issue a press release reporting financial results for the fourth...
The Female Health Company / Veru Healthcare Appoints Brian J. Groch as Chief Commercial Officer
Jan 05, 2017 13:30 pm UTC| Business
MIAMI, Jan. 05, 2017 -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced the appointment of Brian J. Groch as Chief Commercial Officer, effective January 1, 2017. He will report to Mitchell...
CORRECTING and REPLACING – Avadel Pharmaceuticals Provides 2017 Guidance and Business Update
Jan 05, 2017 13:18 pm UTC| Business
In a release issued under the same headline earlier today by Avadel Pharmaceuticals plc(NASDAQ:AVDL)please note that in the second subheadof the release, the Adjusted Diluted EPS should be $0.20 - $0.35, not $0.20 -...
UPDATE -- BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors
Jan 05, 2017 13:14 pm UTC| Business
BRANFORD, Conn., Jan. 05, 2017 -- BioXcel, a privately held biopharmaceutical company pioneering the integration of big data analytics and machine learning-based artificial intelligence (AI) with drug development...